An Interview with Carl June, MD, a Pioneer in CAR T-cell Therapy
In 2012, Carl June, MD, a pioneer in the development of chimeric antigen receptor (CAR) T-cell therapy, helped treat Emily Whitehead, the...
Tag: CAR T-cell therapy
In 2012, Carl June, MD, a pioneer in the development of chimeric antigen receptor (CAR) T-cell therapy, helped treat Emily Whitehead, the...
“The field of cell therapy is one of the most exciting fields in translational medicine,” began Katayoun Rezvani, MD, PhD,...
A pair of studies presented at the AACR Annual Meeting 2019 demonstrated encouraging clinical outcomes with two different chimeric...
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
In the 1970s television series The Six Million Dollar Man, the narrator says of severely injured astronaut Steve Austin:...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved expanding the use of the immunotherapeutic tisagenlecleucel (Kymriah)...
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
A study presented in the AACR Annual Meeting 2018 Media Preview webinar, held March 15, examined closely a key...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a revolutionary new type of immunotherapy...